EUVIMEDEUVIMED entdecken
KorrekturOpen Access

Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo

Liping Zhong, Wei Shi, Lu Gan, Xiuli Liu, Yu Huo, Pan Wu, Zhikun Zhang, Tao Wu, Hongmei Peng, Yong Huang, Yongxiang Zhao, Yulin Yuan und 2 weitere

Theranostics · 05.08.2025 · 15 (16) · 8704-8705

DOI: 10.7150/thno.117883 ↗

Kurz gefasst

Korrektur in der Zeitschrift Theranostics, erschienen am 05.08.2025. Verfasst von Liping Zhong und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Guangxi Medical Unive…. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • National Center for International Research of Bio-targeting Theranostics, Guangxi Key Laboratory of Bio-targeting Theranostics, Guangxi Medical University, Nanning, Guangxi 530021, China. Collaborative Innovation Center…
  • The First People's Hospital of Changde City, Changde, Hunan 41500, China.
  • Department of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, Guangxi 530023, China.
  • Department of Laboratory Medicine, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi 530021, China.
  • Department of Scientific Research, The Affiliated Fangchenggang Hospital, Guangxi University of Chinese Medicine, Fangchenggang, Guangxi 538001, China.

Zitieren

APA

Zhong, L., Shi, W., Gan, L., Liu, X., Huo, Y., Wu, P., Zhang, Z., Wu, T., Peng, H., Huang, Y., Zhao, Y., Yuan, Y., Deng, Z., & Tang, H. (2025). Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo. Theranostics, 15(16), 8704-8705. https://doi.org/10.7150/thno.117883

Vancouver

Zhong L, Shi W, Gan L, Liu X, Huo Y, Wu P, et al. Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo. Theranostics. 2025;15(16):8704-8705. doi:10.7150/thno.117883

BibTeX
@article{Zhong2025,
  author = {Zhong, Liping and Shi, Wei and Gan, Lu and Liu, Xiuli and Huo, Yu and Wu, Pan and Zhang, Zhikun and Wu, Tao and Peng, Hongmei and Huang, Yong and Zhao, Yongxiang and Yuan, Yulin and Deng, Zhiming and Tang, Hongliang},
  title = {Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivo},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {16},
  pages = {8704--8705},
  doi = {10.7150/thno.117883}
}
Kostenlos starten →